Biofilm inhibitory efficiency of phytol in combination with cefotaxime against nosocomial pathogen Acinetobacter baumannii

Journal of Applied Microbiology
S RamanathanV R Arumugam

Abstract

This study aimed to evaluate the antibiofilm potential of phytol and cefotaxime combinations (PCCs) against Acinetobacter baumannii and to elucidate the molecular mechanism of their antibiofilm potential through the transcriptomic approach. Phytol and cefotaxime combination(s) (PCC(s) [160 μg ml-1  + 8 μg ml-1 for microbial type culture collection (MTCC) strain and 160 μg ml-1  + 0.5 μg ml-1 for clinical isolate] effectively inhibited the A. baumannii biofilm formation. Additionally, light, confocal laser scanning and scanning electron microscopic analyses validated the antibiofilm potential of PCCs. Furthermore, PCCs treated A. baumannii cells showed a decreased level of hydrophobicity index compared to their respective controls. Fourier-transform infrared (FT-IR) spectra of exopolysaccharide matrix extracted from PCCs-treated A. baumannii cells showed a visible decrease in absorbance of polysaccharides, nucleic acids and protein regions compared to the spectra of untreated controls. In the blood sensitivity assay, the PCCs-treated A. baumannii plates showed reduced a number of bacterial colonies compared to their control plates. Reduced level of catalase production was also observed in the PCCs treatment compared to their con...Continue Reading

References

Jul 16, 2002·Infection and Immunity·Tomás Maira-LitránGerald B Pier
Jul 27, 2002·Annual Review of Microbiology·P StoodleyJ W Costerton
Dec 23, 2004·JAMA : the Journal of the American Medical Association·Lisa L MaragakisTrish M Perl
May 20, 2006·Bulletin of the World Health Organization·Xavier Seuba
Jun 15, 2007·FEMS Microbiology Letters·Stephen G J SmithRobert P Fagan
Jul 13, 2007·Applied Microbiology and Biotechnology·JianLan YouShiNing Zhou
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Nov 21, 2007·Journal of Bacteriology·Thomas W LoehfelmAnthony A Campagnari
Jan 30, 2008·Pharmacotherapy·Anthony M NicasioDavid P Nicolau
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter J SebenyKyle Petersen
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
May 30, 2009·Ecotoxicology and Environmental Safety·Xiaoyan LinYangyang Dong
Mar 17, 2010·Applied and Environmental Microbiology·Yongqin JiaoMichael P Thelen
May 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M SengstockK S Kaye
May 17, 2011·FEMS Immunology and Medical Microbiology·Nadia Kazemi PourBalu A Chopade
May 10, 2012·FEMS Microbiology Reviews·Michael J McConnellJerónimo Pachón
Jul 6, 2012·Clinical Microbiology Reviews·Pranita D TammaLisa L Maragakis
Sep 29, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Juliana Lanna PassosRobert Weingart Barreto
Aug 21, 2013·Applied and Environmental Microbiology·H M Sharon GohMark A Schembri
Jan 16, 2014·Natural Product Research·B PejinM Mojovic
Aug 22, 2015·Journal of Medical Microbiology·Ganapathy Ashwinkumar SubrameniumShunmugiah Karutha Pandian
Jan 5, 2016·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wenjuan WeiJiabin Li
Aug 4, 2016·Frontiers in Microbiology·Angélique MontaguPatrick Saulnier
Dec 21, 2016·Antimicrobial Agents and Chemotherapy·Crystal L JonesDaniel V Zurawski
Jul 16, 2017·Microbial Pathogenesis·Arunachalam KannappanArumugam Veera Ravi
Sep 13, 2017·Journal of Medical Microbiology·Arunachalam KannappanArumugam Veera Ravi
Dec 21, 2017·Frontiers in Cellular and Infection Microbiology·Ramanathan SrinivasanArumugam Veera Ravi

❮ Previous
Next ❯

Citations

May 31, 2019·Biofouling·Ravindran DurgadeviShunmugaiah Karutha Pandian
Dec 16, 2020·Scientific Reports·Anthonymuthu SelvarajShunmugiah Karutha Pandian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.